APA (7th ed.) Citation

H, K., M, N., J, T., M, K., S, U., M, K., . . . Y, M. (2026). Prognostic significance of peripheral myeloid-derived suppressor cells in advanced breast cancer. Breast cancer (Tokyo, Japan), 33(3), 601. https://doi.org/10.1007/s12282-026-01831-w

Chicago Style (17th ed.) Citation

H, Kanaoka, et al. "Prognostic Significance of Peripheral Myeloid-derived Suppressor Cells in Advanced Breast Cancer." Breast Cancer (Tokyo, Japan) 33, no. 3 (2026): 601. https://doi.org/10.1007/s12282-026-01831-w.

MLA (9th ed.) Citation

H, Kanaoka, et al. "Prognostic Significance of Peripheral Myeloid-derived Suppressor Cells in Advanced Breast Cancer." Breast Cancer (Tokyo, Japan), vol. 33, no. 3, 2026, p. 601, https://doi.org/10.1007/s12282-026-01831-w.